Christiane E. Whetstone
Hamilton, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
Investigational agents targeting alarmins for asthma treatment: insights and progress from phase I and II trials.
Journal: Expert opinion on investigational drugs
Published: February 18, 2026
Recent updates on thymic stromal lymphopoietin as a therapeutic target for asthma.
Journal: Expert review of respiratory medicine
Published: January 19, 2026
Reply to: Is the role of eosinophils in refractory chronic cough truly dismissed? Mepolizumab reduced blood and sputum eosinophils, but not eosinophil-derived neurotoxin.
Journal: The European respiratory journal
Published: January 19, 2026
Pathobiology of atopic dermatitis and association with disease severity after acute oral steroid treatment.
Journal: The journal of allergy and clinical immunology. Global
Published: October 07, 2025
Evidence of Eczematous Skin Characteristics in Mild Allergic Asthma.
Journal: Clinical and translational allergy
Published: June 10, 2025
Predicting airway hyperresponsiveness to methacholine in patients with atopic dermatitis.
Journal: The journal of allergy and clinical immunology. Global
Published: June 06, 2025
Pathobiology and Regulation of Eosinophils, Mast Cells, and Basophils in Allergic Asthma.
Journal: Immunological reviews
Published: February 10, 2025
Benralizumab Depletes IL-5Rα-Bearing Cells in Skin Lesions of Patients With Atopic Dermatitis.
Journal: Clinical and translational allergy
Published: December 29, 2024
Regulation of Airway Epithelial-Derived Alarmins in Asthma: Perspectives for Therapeutic Targets.
Journal: Biomedicines
Published: September 23, 2024
Immune Response Dynamics and Biomarkers in COVID-19 Patients.
Journal: International journal of molecular sciences
Published: May 15, 2024
Neuromedin-U Mediates Rapid Activation of Airway Group 2 Innate Lymphoid Cells in Mild Asthma.
Journal: American journal of respiratory and critical care medicine
Published: April 10, 2024
Benralizumab for allergic asthma: a randomised, double-blind, placebo-controlled trial.
Journal: The European respiratory journal
Published: March 20, 2024
Last Updated: 09/26/2026